Back
Agios Pharmaceuticals Vs. Arcutis Biotherapeutics Industry Stock Comparison
Sell
24
AGIO
Agios Pharmaceuticals
Last Price:
41.31
Seasonality Move:
0.18%
Sell
40
ARQT
Arcutis Biotherapeutics
Last Price:
10.03
Seasonality Move:
-16.47%
Sell
24
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $40.56. The Score for AGIO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.17. The Score for ARQT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $40.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 34.39 | Sell |
Chaikin Money Flow: | -393176 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.28 - 46.96) | Sell |
Bollinger Bands (100): | (39.66 - 47.96) | Sell |
ARQT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 53.91 | Buy |
Chaikin Money Flow: | -1229448 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.63 - 10.75) | Sell |
Bollinger Bands (100): | (8.55 - 10.37) | Buy |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.82 | Sell |
20-day SMA: | 45.14 | Sell |
50-day SMA: | 45.24 | Sell |
200-day SMA: | 35.73 | Buy |
8-day EMA: | 43.69 | Sell |
20-day EMA: | 44.81 | Sell |
50-day EMA: | 44.75 | Sell |
200-day EMA: | 38.02 | Buy |
ARQT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.57 | Buy |
20-day SMA: | 10.05 | Buy |
50-day SMA: | 9.8 | Buy |
200-day SMA: | 8.56 | Buy |
8-day EMA: | 9.81 | Buy |
20-day EMA: | 9.89 | Buy |
50-day EMA: | 9.83 | Buy |
200-day EMA: | 9.03 | Buy |
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $7.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.55 per share, and a decrease next year of $7.11 per share.
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.38 per share.
Agios Pharmaceuticals Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arcutis Biotherapeutics Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |